Related Experiment Video
Updated: Aug 15, 2026

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Bidirectional cross-modal attention with adaptive gating for multimodal alzheimer's disease classification
Xiaoli Yang1, Chenchen Wang1, Xiao Li1
1Henan University of Science and Technology, School of Medical Technology and Engineering, Luoyang, 471023, China.
None:
Alzheimer's disease (AD) is a neurodegenerative disorder, and mild cognitive impairment (MCI) represents a transitional stage between AD and cognitively normal (CN) individuals. Early diagnosis is clinically important for delaying disease progression. To address the limitations of single-modal approaches and the insufficient modeling of complex cross-modal interactions in existing multimodal fusion methods, this paper proposes a multimodal deep learning classification framework integrating structural magnetic resonance imaging (sMRI) and clinical features. The framework employs a 3D ResNet-34 to extract imaging features and a multilayer perceptron (MLP) to encode clinical data. A bidirectional cross-modal attention mechanism enhances associations between imaging and clinical modalities, followed by an adaptive gated fusion module that dynamically integrates concatenated global multimodal features with cross-modal interaction features. To evaluate the robustness of the proposed framework, all experiments were repeated using five different random seeds, and the results are reported as mean ± standard deviation. Experimental results demonstrate competitive performance across multiple classification tasks, achieving accuracies of 95.67% ± 1.70% for three-class classification (CN vs. MCI vs. AD) and 93.64% ± 2.36% for four-class classification (CN vs. early MCI (EMCI) vs. late MCI (LMCI) vs. AD). For binary classification (AD vs. CN, AD vs. MCI, MCI vs. CN, and EMCI vs. LMCI), the method achieves accuracies of 96.83% ± 1.53%, 95.33% ± 1.00%, 95.83% ± 1.39%, and 93.61% ± 2.35%, respectively. The proposed framework provides an effective solution for multimodal deep learning-based computer-aided diagnosis of AD.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
